Advertisement
Screener

VISTAGEN THERAPEUTICS, INC. (VTGN) Notes Issued

2.8 / 5 stars · 68/120 Roast Me

VISTAGEN THERAPEUTICS, INC. Notes Issued

VISTAGEN THERAPEUTICS, INC. (VTGN) reported Notes Issued of $0 for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:NotesIssued1 · last filed 2026-08-14

  • VISTAGEN THERAPEUTICS, INC. notes issued for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
  • VISTAGEN THERAPEUTICS, INC. notes issued for the quarter ending 2025-06-30 was $1.02M.
  • VISTAGEN THERAPEUTICS, INC. notes issued for the quarter ending 2015-06-23 was $280.00K.
Period endNotes Issued 1 monthNotes Issued 1 month as first filedNotes Issued 3 month
2026-06-30$0.00
10-Q · filed 2026-08-14
2025-06-30$1.02M
10-Q · filed 2026-08-14
2015-06-23$280.00K
10-K · filed 2015-06-29
2014-02-04$1.47M
10-K · filed 2014-06-25
$390.00K
10-Q · filed 2014-02-14

Similar stocks

Stock NameCountryMarket CapPE Ratio
MUSTANG BIO, INC. (MBIO)United States$0.013B
AEON Biopharma, Inc. (AEON)United States$0.013B-0.36
LISATA THERAPEUTICS, INC. (LSTA)United States$0.014B-2.13
Tempest Therapeutics, Inc. (TPST)United States$0.013B
Aspire Biopharma Holdings, Inc. (ASBP)United States$0.012B-0.60
BIOVIE INC. (BIVI)United States$0.012B
BullFrog AI Holdings, Inc. (BFRG)United States$0.014B
ADIAL PHARMACEUTICALS, INC. (ADIL)United States$0.012B
Vyome Holdings, Inc (HIND)United States$0.014B-1.38
Tvardi Therapeutics, Inc. (TVRD)United States$0.014B